InvestorsHub Logo
icon url

Preciouslife1

01/30/21 10:54 AM

#336405 RE: EndoTarget #336404

Amazing that IF continued rapid expansion of existing capabilities creates the capacity for parabolic growth potential and hence increased earnings, and exposure within the Pharma, Biotech industries .... Amazon started at a simple desk with a homemade AMAZON sign on the wall, as a simple book reseller ... NAYSAYERS GONNA NAYSAY, but the underlying strength of share price in a highly volatile and trending down market shows the new resiliency and perseverance of CDMO .... ALL IMHO. ... BLESSINGS upon blessings to all longs and especially all the long standing and holding shareholders some of us since the 1990’s!
icon url

bfiest

01/30/21 12:49 PM

#336408 RE: EndoTarget #336404

Just a guess but I think competition is of little concern in an industry where capacity is in dire need. There is more than enough business to go around. Avid now has everything in place to continue to excel in the foreseeable future. They really have done an excellent job putting the necessary puzzle pieces in place. About the only thing we could wish for at this point is more rapid execution of expansion. AIMO